INOmax DS: The latest advance in INOMAX delivery systems

INOMAX^® is a vasodilator, which, in conjunction with ventilatory support and other appropriate agents, is indicated for the treatment of term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, where it improves oxygenation and reduces the need for extracorporeal membrane oxygenation.

INOMAX Important Safety Information (ISI)
INOMAX should not be used in the treatment of neonates known to be dependent on right-to-left shunting of blood

Read Full ISI

Downloads

INOmax DS

We understand patient bedside and transport needs

Ikaria^® understands how the efficient administration of INOMAX at the patient’s bedside or during transport are vital to the care of term and near-term newborns with Hypoxic Respiratory Failure.

Limited space and weight in a helicopter or ambulance necessitates efficient, highly functional design
Need for extended battery life during vital transport
Monitor interface must facilitate fast response
Dosing flexibility must allow for variable patient needs

INOmax DS—an enhanced experience

Next generation INOvent^®
Compact size and weight
Designed for rapid response
Extended battery life of up to 6 hours
Easy-to-use interface for fast response and quick monitoring
User-friendly, color touch screen interface with multifunction alarms to ensure at-a-glance monitoring
Two backup delivery options
- With INOblender, manual ventilation and selectable INOMAX dose of 5 ppm to 80 ppm
- Uninterrupted ventilation with fixed flow of INOMAX

INOmax DS is compatible with many of your ventilation and respiratory strategies

INOmax DS drug delivery system is compatible with over 44 invasive mechanical ventilation methods and noninvasive respiratory strategies, including CPAP and nasal cannula,* and is equipped with safety sensors for monitoring nitric oxide (NO), oxygen (O₂), and nitrogen dioxide (NO₂)

*Please see sales representative to find out if your ventilator is compatible with INOVENT or INOMAX DS.

To learn more or to schedule an appointment with one of your INOMAX representatives, medical science liaisons, or service technicians, please call 1-877-566-9466. For additional information, please Contact Us.

References

The product information provided in this site is intended only for residents of the United States.
The product discussed herein may have different product labeling in different countries.

INOMAX Important Safety Information

INOMAX should not be used in the treatment of neonates known to be dependent on right-to-left shunting of blood
Methemoglobinemia is a dose-dependent side effect of inhaled nitric oxide therapy. Therefore, methemoglobin levels should be monitored during INOMAX administration. Caution should be used when administering INOMAX with other drugs that can cause methemoglobinemia regardless of their route of administration
Nitrogen dioxide (NO₂) forms rapidly in gas mixtures containing nitric oxide and oxygen. NO₂ formed in this way can cause airway inflammation and damage
INOMAX must be administered through a system that does not cause excessive generation of NO₂ and that monitors for NO, NO₂, and FiO₂
Abrupt discontinuation of INOMAX therapy can lead to worsening of PaO₂ and increasing pulmonary artery pressure (PAP). Deterioration in oxygenation and elevation in PAP can also occur in children with no apparent response to INOMAX
In patients with pre-existing left ventricular dysfunction, inhaled nitric oxide may increase pulmonary capillary wedge pressure leading to pulmonary edema

Please see Full Prescribing Information.

Refer a Colleague to INOMAX^®

Disclaimer

*Please note: When you access these resources, you are leaving the INOMAX website. Therefore, INOMAX and Ikaria Holdings Inc. do not endorse the accuracy of the information you may find. We encourage you to talk to your doctor about the accuracy of any information you discover through these Internet resources.

Agree and continue →